深圳市海滨制药有限公司
Clinical Trials
0
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
53
NMPA:53
Drug Approvals
Famotidine，Calcium Carbonate and Magnesium Hydroxide Chewable Tablets
- Product Name
- 法莫替丁钙镁咀嚼片
- Approval Number
- 国药准字H20080129
- Approval Date
- Jul 7, 2023
NMPA
Long Chain Fat Emulsion Injection (OO)
- Product Name
- 长链脂肪乳注射液(OO)
- Approval Number
- 国药准字H20233345
- Approval Date
- Mar 24, 2023
NMPA
Long Chain Fat Emulsion Injection (OO)
- Product Name
- 长链脂肪乳注射液(OO)
- Approval Number
- 国药准字H20233346
- Approval Date
- Mar 24, 2023
NMPA
Alogliptin Benzoate Tablets
- Product Name
- 苯甲酸阿格列汀片
- Approval Number
- 国药准字H20213302
- Approval Date
- Apr 27, 2021
NMPA
ω-3- Fish Oil Medium and Long Chain Fat Emulsion Injection
- Product Name
- ω-3鱼油中/长链脂肪乳注射液
- Approval Number
- 国药准字H20203672
- Approval Date
- Dec 11, 2020
NMPA
ω-3- Fish Oil Medium and Long Chain Fat Emulsion Injection
- Product Name
- ω-3鱼油中/长链脂肪乳注射液
- Approval Number
- 国药准字H20203671
- Approval Date
- Dec 11, 2020
NMPA
- Prev
- 1
- 2
- 3
- 4
- 5
- 6
- Next
Clinical Trials
No trials found
News
No news found